CONTACT-01: A Randomized Phase III Trial of Atezolizumab + Cabozantinib Versus Docetaxel for Metastatic Non-Small Cell Lung Cancer After a Checkpoint Inhibitor and Chemotherapy
Hoffmann-La Roche
Joel Neal; Nick Pavlakis; Sang-We Kim; Yasushi Goto; Sun Min Lim; Giannis Mountzios; Elena Fountzilas; Anastasia Mochalova; Daniel C Christoph; Alessandra Bearz; Xavier Quantin; Ramon Palmero; Vladan Antic; Elaine Chun; Tirupathi Rao Edubilli; Ya-Chen Lin; Mahrukh Huseni; Marcus Ballinger; Vilma Graupner; Dominic Curran; Piet Vervaet; Thomas Newsom-Davis